1. Home
  2. ADAG vs SKLZ Comparison

ADAG vs SKLZ Comparison

Compare ADAG & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • SKLZ
  • Stock Information
  • Founded
  • ADAG 2011
  • SKLZ 2012
  • Country
  • ADAG China
  • SKLZ United States
  • Employees
  • ADAG N/A
  • SKLZ N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • SKLZ EDP Services
  • Sector
  • ADAG Health Care
  • SKLZ Technology
  • Exchange
  • ADAG Nasdaq
  • SKLZ Nasdaq
  • Market Cap
  • ADAG 76.3M
  • SKLZ 80.3M
  • IPO Year
  • ADAG 2021
  • SKLZ N/A
  • Fundamental
  • Price
  • ADAG $1.90
  • SKLZ $6.30
  • Analyst Decision
  • ADAG Strong Buy
  • SKLZ Buy
  • Analyst Count
  • ADAG 1
  • SKLZ 2
  • Target Price
  • ADAG $8.00
  • SKLZ $10.75
  • AVG Volume (30 Days)
  • ADAG 75.3K
  • SKLZ 46.5K
  • Earning Date
  • ADAG 07-24-2025
  • SKLZ 07-31-2025
  • Dividend Yield
  • ADAG N/A
  • SKLZ N/A
  • EPS Growth
  • ADAG N/A
  • SKLZ N/A
  • EPS
  • ADAG N/A
  • SKLZ N/A
  • Revenue
  • ADAG $103,204.00
  • SKLZ $92,644,000.00
  • Revenue This Year
  • ADAG $6,488.89
  • SKLZ $0.20
  • Revenue Next Year
  • ADAG $57.50
  • SKLZ $14.10
  • P/E Ratio
  • ADAG N/A
  • SKLZ N/A
  • Revenue Growth
  • ADAG N/A
  • SKLZ N/A
  • 52 Week Low
  • ADAG $1.33
  • SKLZ $3.54
  • 52 Week High
  • ADAG $3.58
  • SKLZ $7.31
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 52.47
  • SKLZ 59.83
  • Support Level
  • ADAG $1.73
  • SKLZ $6.07
  • Resistance Level
  • ADAG $2.02
  • SKLZ $6.39
  • Average True Range (ATR)
  • ADAG 0.15
  • SKLZ 0.16
  • MACD
  • ADAG -0.01
  • SKLZ -0.05
  • Stochastic Oscillator
  • ADAG 42.50
  • SKLZ 77.54

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

About SKLZ Skillz Inc.

Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

Share on Social Networks: